[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Treatment for Syndromes of Dementia and Movement Disorders Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

December 2020 | 108 pages | ID: T12925D7A47EEN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Treatment for Syndromes of Dementia and Movement Disorders market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Treatment for Syndromes of Dementia and Movement Disorders market segmented into
  • Movement Disorders
  • Progressive Dementia
  • Progressive Dementia with Neurological Abnormality (PDNA)
Based on the end-use, the global Treatment for Syndromes of Dementia and Movement Disorders market classified into
  • ?70 Years
  • Above 70 Years
Based on geography, the global Treatment for Syndromes of Dementia and Movement Disorders market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Valeant Pharmaceutical International
  • AstraZeneca GmbH
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Merck
  • Sanofi
  • Novartis
  • Bristol-Myers Squibb
  • Baxter International
  • Pfizer
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL TREATMENT FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS INDUSTRY

2.1 Summary about Treatment for Syndromes of Dementia and Movement Disorders Industry
2.2 Treatment for Syndromes of Dementia and Movement Disorders Market Trends
  2.2.1 Treatment for Syndromes of Dementia and Movement Disorders Production & Consumption Trends
  2.2.2 Treatment for Syndromes of Dementia and Movement Disorders Demand Structure Trends
2.3 Treatment for Syndromes of Dementia and Movement Disorders Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Movement Disorders
  4.2.2 Progressive Dementia
  4.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 ?70 Years
  4.3.2 Above 70 Years

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Movement Disorders
  5.2.2 Progressive Dementia
  5.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 ?70 Years
  5.3.2 Above 70 Years
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Movement Disorders
  6.2.2 Progressive Dementia
  6.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 ?70 Years
  6.3.2 Above 70 Years
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Movement Disorders
  7.2.2 Progressive Dementia
  7.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 ?70 Years
  7.3.2 Above 70 Years
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Movement Disorders
  8.2.2 Progressive Dementia
  8.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 ?70 Years
  8.3.2 Above 70 Years
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Movement Disorders
  9.2.2 Progressive Dementia
  9.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 ?70 Years
  9.3.2 Above 70 Years
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Valeant Pharmaceutical International
  10.1.2 AstraZeneca GmbH
  10.1.3 F. Hoffmann-La Roche
  10.1.4 Abbott Laboratories
  10.1.5 Merck
  10.1.6 Sanofi
  10.1.7 Novartis
  10.1.8 Bristol-Myers Squibb
  10.1.9 Baxter International
  10.1.10 Pfizer
10.2 Treatment for Syndromes of Dementia and Movement Disorders Sales Date of Major Players (2017-2020e)
  10.2.1 Valeant Pharmaceutical International
  10.2.2 AstraZeneca GmbH
  10.2.3 F. Hoffmann-La Roche
  10.2.4 Abbott Laboratories
  10.2.5 Merck
  10.2.6 Sanofi
  10.2.7 Novartis
  10.2.8 Bristol-Myers Squibb
  10.2.9 Baxter International
  10.2.10 Pfizer
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type Overview
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type Market Share List
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type of Major Players
Table Brief Introduction of Valeant Pharmaceutical International
Table Brief Introduction of AstraZeneca GmbH
Table Brief Introduction of F. Hoffmann-La Roche
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Merck
Table Brief Introduction of Sanofi
Table Brief Introduction of Novartis
Table Brief Introduction of Bristol-Myers Squibb
Table Brief Introduction of Baxter International
Table Brief Introduction of Pfizer
Table Products & Services of Valeant Pharmaceutical International
Table Products & Services of AstraZeneca GmbH
Table Products & Services of F. Hoffmann-La Roche
Table Products & Services of Abbott Laboratories
Table Products & Services of Merck
Table Products & Services of Sanofi
Table Products & Services of Novartis
Table Products & Services of Bristol-Myers Squibb
Table Products & Services of Baxter International
Table Products & Services of Pfizer
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) by Region 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Movement Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Progressive Dementia with Neurological Abnormality (PDNA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ?70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Above 70 Years Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Valeant Pharmaceutical International 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of AstraZeneca GmbH 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of F. Hoffmann-La Roche 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Merck 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Bristol-Myers Squibb 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Baxter International 2017-2020e
Figure Treatment for Syndromes of Dementia and Movement Disorders Sales Revenue (Million USD) of Pfizer 2017-2020e


More Publications